Prof. Sherif El-Khamisy
Professor of Molecular Medicine and Director of the Institute of Cancer Therapeutics
Professor Sherif El-Khamisy is a ‘life’-scientist with over 25 years’ experience in the research and innovation ecosystem, focusing on translation and commercialisation. He is trained as a pharmacist followed by a PhD in genomic medicine from the University of Sussex, then a post-doctoral training at St Jude Hospital in the US. Working with the Nobel Laureate Dr Zewail in Caltech, Sherif established and directed one of the first medical genomics research centres in the MENA region. In 2018, Sherif co-founded the healthy Lifespan Institute at the University of Sheffield. In addition to his roles at the University of Sheffield, Sherif is the Director of the Institute of Cancer Therapeutics and Dean of Research at the University of Bradford. Sherif’s core technical background is in genomic medicine with a broader economic focus through working with senior executives and stakeholders. He is a Wellcome Trust Investigator, a Fellow of the Lister Institute of Preventative Medicine and sits on UKRI and Wellcome Trust funding panels. His work in biology and medicine is published in journals such as Nature, Cell and Science. He is an elected Fellow of the Royal Society of Biology, the Royal Society of Chemistry, and his work has been recognized by AstraZeneca (UK), Caltech (USA), Awards of Excellence in Medical Sciences from the Shoman Foundation (Jordon), the Academy of Medical Sciences (Egypt) and the Wellcome Trust (UK).